文献速递肝病炎症性肠病

刺激性MAIT细胞抗原进入循环并被人肝细胞高效代谢和呈递

Stimulatory MAIT cell antigens reach the circulation and are efficiently metabolised and presented by human liver cells.
PubMed 文献 · Gut · 2022-01-20

研究探讨人肝脏中哪种细胞作为MAIT细胞的抗原呈递细胞,以及刺激性抗原在何种条件下进入循环。采用原代人肝细胞进行抗原呈递实验,检测健康人、门静脉高压行经颈静脉肝内门体分流术患者及炎症性肠病患者的血清。发现所有受试肝细胞均刺激MAIT细胞,肝细胞最有效;血清以MR1依赖方式刺激MAIT细胞。

要点

  • 肝细胞是最高效的MAIT细胞抗原呈递细胞。
  • 肝细胞激活MAIT细胞可被非激活型MR1配体阻断。
  • IBD及门静脉高压患者血清以MR1依赖方式刺激MAIT细胞。

核心结论

  • 肝细胞在MAIT细胞抗原代谢和激活中具有此前未认识的作用,抑制该过程可能为设计抗纤维化疗法提供机会。
  • 血清中存在MAIT细胞刺激性抗原,可解释肝脏中观察到的MAIT细胞活化表型。
  • 肠屏障功能受损患者血清中肠源性MAIT细胞刺激性配体水平升高,提示肝内抗原呈递可能是肝病发展的重要步骤。

研究设计与样本

  • 使用原代人肝细胞进行抗原呈递实验,检测对血源性和肝源性MAIT细胞的刺激。
  • 评估健康受试者、门静脉高压行经颈静脉肝内门体分流术支架患者及炎症性肠病患者的血清对MAIT细胞的刺激潜力。

主要发现

  • MAIT细胞散布于健康人肝脏,所有受试肝细胞类型均刺激MAIT细胞,肝细胞最有效。
  • 肝细胞对MAIT细胞的激活由细菌裂解物和纯抗原诱导,并被非激活型MR1配体阻止。
  • 来自外周血、门静脉血及IBD患者的血清以MR1依赖方式刺激MAIT细胞。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Mucosal-associated invariant T (MAIT) cells are the most abundant T cells in human liver. They respond to bacterial metabolites presented by major histocompatibility complex-like molecule MR1. MAIT cells exert regulatory and antimicrobial functions and are implicated in liver fibrogenesis. It is not well understood which liver cells function as antigen (Ag)-presenting cells for MAIT cells, and under which conditions stimulatory Ags reach the circulation. DESIGN: We used different types of primary human liver cells in Ag-presentation assays to blood-derived and liver-derived MAIT cells. We assessed MAIT cell stimulatory potential of serum from healthy subjects and patients with portal hypertension undergoing transjugular intrahepatic portosystemic shunt stent, and patients with inflammatory bowel disease (IBD). RESULTS: MAIT cells were dispersed throughout healthy human liver and all tested liver cell types stimulated MAIT cells, hepatocytes being most efficient. MAIT cell activation by liver cells occurred in response to bacterial lysate and pure Ag, and was prevented by non-activating MR1 ligands. Serum derived from peripheral and portal blood, and from patients with IBD stimulated MAIT cells in MR1-dependent manner. CONCLUSION: Our findings reveal previously unrecognised roles of liver cells in Ag metabolism and activation of MAIT cells, repression of which creates an opportunity to design antifibrotic therapies. The presence of MAIT cell stimulatory Ags in serum rationalises the observed activated MAIT cell phenotype in liver. Increased serum levels of gut-derived MAIT cell stimulatory ligands in patients with impaired intestinal barrier function indicate that intrahepatic Ag-presentation may represent an important step in the development of liver disease.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Lett MJ, Mehta H, Keogh A, et al. Stimulatory MAIT cell antigens reach the circulation and are efficiently metabolised and presented by human liver cells. Gut. 2022. PMID: 35058274. doi:10.1136/gutjnl-2021-324478

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。